Press Release Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution Kiniksa Pharmaceuticals International, Plc · Jul 28
Press Release Kazia Therapeutics Announces the Filing of Provisional Patent for Novel Strategy, Supported by Preclinical Data, to Prevent Metastatic Recurrence in Triple-Negative Breast Cancer Kazia Therapeutics Ltd · Jul 28
Press Release ZenaTech’s ZenaDrone Begins Testing Phase for Interceptor P-1 Counter-UAS Drone Platform ZenaTech Inc. · Jul 28
Press Release Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference Plus Therapeutics Inc. · Jul 28
Press Release Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD) Dyne Therapeutics, Inc. · Jul 28
Press Release Riot Announces Second Quarter 2026 Earnings Conference Call Riot Platforms, Inc. · Jul 28
Press Release Department of Culture and Tourism – Abu Dhabi Announces 11 December 2026 Opening of Guggenheim Abu Dhabi Department of Culture and Tourism - Abu Dhabi · Jul 28
Press Release China Literature to Report First Half 2026 Financial Results on August 11, 2026 China Literature · Jul 28
Press Release VR Confirms New IP and Conductivity Anomalies on its Bonita Property Porphyry Copper-Gold Project in Nevada VR Resources Ltd. · Jul 28
Press Release National Civil Rights Museum Hosts the 2026 Ruby Bridges Reading Festival National Civil Rights Museum · Jul 28
Press Release Atea Pharmaceuticals Meets Both Its Primary and Secondary Endpoints in the Phase 3 C-BEYOND North America Trial Evaluating Bemnifosbuvir/Ruzasvir for Hepatitis C Virus Atea Pharmaceuticals, Inc. · Jul 28
Press Release Lungpacer Announces Health Economic Analysis Demonstrating Clinical and Cost Benefits of AeroPace in Mechanically Ventilated Patients Lungpacer Medical USA Inc. · Jul 28